Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?

References

• From the global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2014 [cited 2015 Dec 1]. Available from: http://www.Goldcopd.Org/.
   Google Scholar
• Guidance for Industry. Patient-reported Outcome Measures: Use in Medical Product Delvelopment to Support Labelling Claims. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH); 2009. [ cited 2015 Sept 23]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
   Google Scholar
• Guidance for Industry and FDA Staff. Qualification Process for Drug Development Tools. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2014. cited 2015 Sept 23]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM230597.pdf.
   Google Scholar
• Cazzola M, Hanania NA, MacNee W, et al. A review of the most common patient-reported outcomes in COPD–revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis. 2015;10:725–738.
   PubMed Web of Science ®Google Scholar
• Ekstrom M, Currow DC, Johnson MJ. Outcome measurement of refractory breathlessness: endpoints and important differences. Curr Opin Support Palliat Care. 2015;9(3):238–243.
   PubMed Web of Science ®Google Scholar
• Blinderman CD, Homel P, Billings JA, et al. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009;38(1):115–123.
   PubMed Web of Science ®Google Scholar
• Kessler R, Partridge MR, Miravitlles M, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–272.
   PubMed Web of Science ®Google Scholar
• Patrick DL, Guyatt GH, Acquadro C, et al. Patient reported outcomes. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration; 2011. [updatedMarch]. Available from: www.cochrane-handbook.org.)
   Google Scholar
• Hodson M, Andrew S, Michael Roberts C. Towards an understanding of PREMS and PROMS in COPD. Breathe. 2013;9(5):358–364.
   Google Scholar
• Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880–887.
   PubMed Web of Science ®Google Scholar
• Jones P, Miravitlles M, Van Der Molen T, et al. Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697–709.
   PubMed Web of Science ®Google Scholar
• Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440.
   PubMed Web of Science ®Google Scholar
• Casanova C, Marin JM, Martinez-Gonzalez C, et al. Differential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest. 2015;148(1):159–168.
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–419.
   PubMed Web of Science ®Google Scholar
• Casanova C, Cote C, De Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(6):591–597.
   PubMed Web of Science ®Google Scholar
• Jones PW, Donohue JF, Nedelman J, et al. Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis. Respir Res. 2011;12:161.
   Google Scholar
• Banzett RB, Adams L, O’Donnell CR, et al. Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response. Am J Respir Crit Care Med. 2011;184(8):920–927.
   PubMed Web of Science ®Google Scholar
• Wadell K, Webb KA, Preston ME, et al. Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD. Copd. 2013.
   PubMedGoogle Scholar
• Miravitlles M, Ferrer J, Baro E, et al. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med. 2013;107(12):1977–1985.
   PubMed Web of Science ®Google Scholar
• Montes De Oca M, Tálamo C, Halbert RJ, et al. Health status perception and airflow obstruction in five Latin American cities: the PLATINO study. Respir Med. 2009;103(9):1376–1382.
   PubMed Web of Science ®Google Scholar
• Simon ST, Altfelder N, Alt-Epping B, et al. Is breathlessness what the professional says it is? Analysis of patient and professionals’ assessments from a German nationwide register. Support Care Cancer. 2014;22(7):1825–1832.
   PubMed Web of Science ®Google Scholar
• Santiveri C, Espinalt M, Díaz Carrasco FX, et al. Evaluation of male COPD patients’ health status by proxies. Respir Med. 2007;101(3):439–445.
   PubMed Web of Science ®Google Scholar
• Puhan MA, Behnke M, Devereaux PJ, et al. Measurement of agreement on health-related quality of life changes in response to respiratory rehabilitation by patients and physicians–a prospective study. Respir Med. 2004;98(12):1195–1202.
   PubMed Web of Science ®Google Scholar
• Ahmadi Z, Lundström S, Janson C, et al. End-of-life care in oxygen-dependent COPD and cancer: a national population-based study. Eur Respir J. 2015.
   PubMed Web of Science ®Google Scholar
• Campbell ML, Templin T, Walch J. A respiratory distress observation scale for patients unable to self-report dyspnea. J Palliat Med. 2010;13(3):285–290.
   PubMed Web of Science ®Google Scholar
• Yorke J, Horton M, Jones PW. A critique of Rasch analysis using the dyspnoea-12 as an illustrative example. J Adv Nurs. 2012;68(1):191–198.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–745.
   PubMed Web of Science ®Google Scholar
• Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104.
   PubMed Web of Science ®Google Scholar
• Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415.
   PubMedGoogle Scholar
• Jones P, Beeh K, Chapman K, et al. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77(4):371–383.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Currow DC, Booth S. Prevalence and assessment of breathlessness in the clinical setting. Expert Rev Respir Med. 2014;8(2):151–161.
   PubMed Web of Science ®Google Scholar
• Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J. 2014;43(6):1750–1762.
   PubMed Web of Science ®Google Scholar
• Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327(7414):523–528.
   PubMed Web of Science ®Google Scholar
• Moens K, Higginson IJ, Harding R. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manage. 2014;48(4):660–677.
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2(12):979–987.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85(6):751–758.
   PubMed Web of Science ®Google Scholar
• Borg G. A category scale with ratio properties for intermodal and interindividual comparisons. In: Geissler HG, Petzol P, editors. Psychophysical judgement and the process of perception. Proceedings of the 22nd international congress of psychology. Amsterdam (The Netherlands): North Holland Publishing Co; 1980. p. 25–34.
   Google Scholar
• Leidy N, Sexton C, Jones P, et al. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax. 2014;69:424–430.
   Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Horowitz MB. Perception of breathlessness during exercise in patients with respiratory disease. Med Sci Sports Exerc. 1994;26(9):1078–1081.
   PubMed Web of Science ®Google Scholar
• Watkins ML, Tk W, Tabberer M, et al. Shortness of breath with daily activities questionnaire: validation and responder thresholds in patients with chronic obstructive pulmonary disease. BMJ Open. 2013;3(10):e003048.
   PubMed Web of Science ®Google Scholar
• Eakin EG, Resnikoff PM, Prewitt LM, et al. Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. University of California, San Diego. Chest. 1998;113(3):619–624.
   PubMed Web of Science ®Google Scholar
• Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax. 2010;65(1):21–26.
   PubMed Web of Science ®Google Scholar
• Banzett RB, O’Donnell CR, Guilfoyle TE, et al. Multidimensional dyspnea profile: an instrument for clinical and laboratory research. Eur Respir J. 2015;45(6):1681–1691.
   PubMed Web of Science ®Google Scholar
• Clark W, Yang JC, Tsui S-L, et al. Unidimensional pain rating scales: a multidimensional affect and pain survey (MAPS) analysis of what they really measure. Pain. 2002;98(3):241–247.
   PubMed Web of Science ®Google Scholar
• Hareendran A, Leidy NK, Bu M, et al. Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:345–355.
   PubMed Web of Science ®Google Scholar
• Wilcock A, Crosby V, Clarke D, et al. Repeatability of breathlessness measurements in cancer patients. Thorax. 1999;54(4):374.
   PubMed Web of Science ®Google Scholar
• Johnson MJ, Bland JM, Oxberry SG, et al. Measuring improvement in dyspnoea: should absolute or relative values be used? Eur Respir J. 2014.
   Web of Science ®Google Scholar
• Fletcher CM. Standardized questionaries on respiratory symptoms: a statement prepared and approved by the MRC committee on the aetiology of chronic bronchitis. Bmj. 1960;2(5213):1665–1665.
   PubMedGoogle Scholar
• Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea index is a total score of one unit. Copd. 2005;2(1):99–103.
   PubMedGoogle Scholar
• Horita N, Miyazawa N, Morita S, et al. Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego shortness of breath questionnaire. Copd. 2014;11(1):26–32.
   PubMedGoogle Scholar
• Leidy N, Murray L, Monz B, et al. Measuring respiratory symptoms of COPD: performance of the EXACT- respiratory symptoms tool (E-RS) in three clinical trials. Respir Res. 2014;15(1):124.
   PubMed Web of Science ®Google Scholar
• Yorke J, Swigris J, Russell AM, et al. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest. 2011;139(1):159–164.
   PubMed Web of Science ®Google Scholar
• Lee AL, Harrison SL, Goldstein RS, et al. Pain and its clinical associations in individuals with copd: A systematic review. Chest. 2015;147(5):1246–1258.
   PubMed Web of Science ®Google Scholar
• Partridge MR, Miravitlles M, Ståhl E, et al. Development and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPD. Eur Respir J. 2010;36(1):96–104.
   PubMed Web of Science ®Google Scholar
• Leidy NK, Rennard SI, Schmier J, et al. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest. 2003;124(6):2182–2191.
   PubMed Web of Science ®Google Scholar
• Al-shair K, Muellerova H, Yorke J, et al. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012;10:100.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Iriberri M, Barrueco M, et al. Usefulness of the LCOPD, CAFS and CASIS scales in understanding the impact of COPD on patients. Respiration. 2013;86(3):190–200.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med. 1997;156(4 Pt 1):1032–1039.
   PubMed Web of Science ®Google Scholar
• Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(5):680–685.
   PubMed Web of Science ®Google Scholar
• Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
   PubMed Web of Science ®Google Scholar
• Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. International quality of life assessment. J Clin Epidemiol. 1998;51(11):1171–1178.
   PubMed Web of Science ®Google Scholar
• EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–778.
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327.
   PubMed Web of Science ®Google Scholar
• Meguro M, Barley EA, Spencer S, et al. Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. Chest. 2007;132(2):456–463.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654.
   PubMed Web of Science ®Google Scholar
• van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13.
   PubMedGoogle Scholar
• Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest. 1995;107(6):1585–1589.
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr., Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247–263.
   PubMed Web of Science ®Google Scholar
• Boueri FM, Bucher-Bartelson BL, Glenn KA, et al. Quality of life measured with a generic instrument (short form-36) improves following pulmonary rehabilitation in patients with COPD. Chest. 2001;119(1):77–84.
   PubMed Web of Science ®Google Scholar
• Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–1108.
   PubMed Web of Science ®Google Scholar
• Rutten-vanMölken M, Roos B, Van Noord JA. An empirical comparison of the St George’s Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax. 1999;54(11):995–1003.
   PubMed Web of Science ®Google Scholar
• Agustí A, Soler JJ, Molina J, et al. Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations? Copd. 2012;9(5):492–498.
   PubMedGoogle Scholar
• Dodd JW, Marns PL, Clark AL, et al. The COPD assessment test (CAT): short- and medium-term response to pulmonary rehabilitation. Copd. 2012;9(4):390–394.
   PubMedGoogle Scholar
• Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Hurst JR, Smith CJ, et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010;137(5):1091–1097.
   PubMed Web of Science ®Google Scholar
• Osman IM, Godden DJ, Friend JA, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax. 1997;52(1):67–71.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204.
   PubMed Web of Science ®Google Scholar
• Jones PW, Chen W-H, Wilcox TK, et al. Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest. 2011;139(6):1388–1394.
   PubMed Web of Science ®Google Scholar
• Leidy NK, Wilcox TK, Jones PW, et al. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health. 2010;13(8):965–975.
   PubMed Web of Science ®Google Scholar
• Leidy NK, Wilcox TK, Jones PW, et al. Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med. 2011;183(3):323–329.
   PubMed Web of Science ®Google Scholar
• Mackay AJ, Donaldson GC, Patel AR, et al. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT). Eur Respir J. 2014;43(3):735–744.
   PubMed Web of Science ®Google Scholar
• Make BJ, Eriksson G, Calverley PM, et al. A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis. 2015;10:201–209.
   PubMed Web of Science ®Google Scholar
• Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010;104(7):1005–1011.
   PubMed Web of Science ®Google Scholar
• Vorrink SN, Kort HS, Troosters T, et al. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res. 2011;12:33.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772–778.
   PubMed Web of Science ®Google Scholar
• Gimeno-Santos E, Frei A, Dobbels F, et al. Validity of instruments to measure physical activity may be questionable due to a lack of conceptual frameworks: a systematic review. Health Qual Life Outcomes. 2011;9:86.
   PubMed Web of Science ®Google Scholar
• Gimeno-Santos E, Raste Y, Demeyer H, et al. The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease. Eur Respir J. 2015;46(4):988–1000.
   PubMed Web of Science ®Google Scholar